Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
ME ›
MENTENRIX
Trademark search for:
MENTENRIX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-02-17 — Application filed
2011-02-21 — Application filed
2011-02-22 — Application filed
2011-05-19 — Approved for pub - principal register
2011-05-19 — Assigned to examiner
2011-06-28 — Published for opposition
2011-06-28 — Official gazette publication confirmation e-mailed
2011-08-23 — Noa e-mailed - sou required from applicant
2012-02-02 — Sou teas extension received
2012-02-02 — Teas change of correspondence received
2012-02-02 — Sou extension 1 filed
2012-02-02 — Sou extension 1 granted
2012-02-04 — Notice of approval of extension request e-mailed
2012-07-10 — Sou teas extension received
2012-07-10 — Teas change of correspondence received
2012-07-10 — Sou extension 2 filed
2012-07-27 — Case assigned to intent to use paralegal
2012-07-31 — Sou extension 2 granted
2012-08-01 — Notice of approval of extension request e-mailed
2013-02-20 — Attorney/dom.rep.revoked and/or appointed
2013-02-20 — Teas revoke/app/change addr of atty/dom rep received
2013-03-15 — Teas change of correspondence received
2013-03-25 — Application abandoned
2013-03-25 — Application abandoned
2013-03-25 — Final status recorded
Owner Information
GlaxoSmithKline Biologicals, S.A.
Rixensart BE
GlaxoSmithKline Biologicals, S.A.
Rixensart BE
Correspondent
Terence A Dixon GLAXOSMITHKLINE LGTM - NY0300 5 CRESCENT DRIVE PHILADELPHIA, PA 19112
Filing Details
Filing Date:
2011-02-17
Status Date:
2013-03-25
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.